InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SciSparc Ltd.

SPRC Clue Score24
Israel Fiscal year ends December CIK 0001611746
$4.47 +0.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.47 −25.50% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 30 Aug 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−2.0Net income2.0Fiscal year 2017Operating income−5.8Net income6.2 +213.3%Fiscal year 2018Operating income−7.2Net income8.5 +36.5%EPS, diluted1.20Fiscal year 2019Operating income−4.1Net income4.7 −45.0%EPS, diluted0.64Fiscal year 2020Operating income−3.3Net income3.5 −24.6%EPS, diluted0.11Fiscal year 2021Operating income−5.8Net income−5.8 −263.8%EPS, diluted73.58Fiscal year 2022Revenue1.3Operating income−8.3Net income−2.6EPS, diluted14.82Fiscal year 2023Revenue2.9 +113.7%Operating income−6.8Net income−5.1EPS, diluted14.43Fiscal year 2024Revenue1.3 −54.6%Operating income−7.3Net income−6.3EPS, diluted1.28
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue n/a n/a n/a n/a n/a n/a 1.3 2.9 1.3
Growth +113.7% −54.6%
Operating income −2.0 −5.8 −7.2 −4.1 −3.3 −5.8 −8.3 −6.8 −7.3
Net income 2.0 6.2 8.5 4.7 3.5 −5.8 −2.6 −5.1 −6.3
Growth +213.3% +36.5% −45.0% −24.6% −263.8%
EPS, diluted n/a n/a 1.20 0.64 0.11 73.58 14.82 14.43 1.28

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Gross margin76.1%Operating margin−615.2%Net margin−192.4%Free cash flow margin−588.3%Fiscal year 2023Gross margin76.3%Operating margin−236.7%Net margin−177.9%Fiscal year 2024Gross margin38.7%Operating margin−560.2%Net margin−481.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin n/a n/a n/a n/a n/a n/a 76.1% 76.3% 38.7%
Operating margin n/a n/a n/a n/a n/a n/a −615.2% −236.7% −560.2%
Net margin n/a n/a n/a n/a n/a n/a −192.4% −177.9% −481.2%
Free cash flow margin n/a n/a n/a n/a n/a n/a −588.3% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−1.5Capital expenditure−0.0Free cash flow−1.5Fiscal year 2017Operating cash flow−4.6Capital expenditure−0.0Free cash flow−4.6Fiscal year 2018Operating cash flow−7.1Capital expenditure−0.0Free cash flow−7.1Fiscal year 2019Operating cash flow−4.7Capital expenditure−0.0Free cash flow−4.7Fiscal year 2020Operating cash flow−4.3Fiscal year 2021Operating cash flow−5.1Capital expenditure−0.0Free cash flow−5.1Fiscal year 2022Operating cash flow−7.9Capital expenditure−0.0Free cash flow−7.9Fiscal year 2023Operating cash flow−5.9Fiscal year 2024Operating cash flow−5.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow −1.5 −4.6 −7.1 −4.7 −4.3 −5.1 −7.9 −5.9 −5.1
Capital expenditure −0.0 −0.0 −0.0 −0.0 n/a −0.0 −0.0 n/a n/a
Free cash flow −1.5 −4.6 −7.1 −4.7 n/a −5.1 −7.9 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash0.7Shareholders’ equity0.6Fiscal year 2017Cash9.2Shareholders’ equity8.4Fiscal year 2018Cash1.5Shareholders’ equity0.2Fiscal year 2019Cash0.9Shareholders’ equity0.0Fiscal year 2020Cash1.9Shareholders’ equity1.4Fiscal year 2021Cash6.9Shareholders’ equity8.1Fiscal year 2022Cash3.6Shareholders’ equity6.4Fiscal year 2023Cash2.1Shareholders’ equity7.6Fiscal year 2024Cash1.5Shareholders’ equity8.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash 0.7 9.2 1.5 0.9 1.9 6.9 3.6 2.1 1.5
Shareholders’ equity 0.6 8.4 0.2 0.0 1.4 8.1 6.4 7.6 8.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024
Operations
−1.5 −4.6 −7.1 −4.7 −4.3 −5.1 −7.9 −5.9 −5.1
Growth
Investment
−0.0 −0.0 −0.0 −0.0 n/a −0.0 −0.0 n/a n/a
calc −1.5 −4.6 −7.1 −4.7 n/a −5.1 −7.9 n/a n/a
Growth
calc n/a n/a n/a n/a n/a −64.51 −45.04 n/a n/a
−0.0 −0.1 −2.1 1.3 0.0 −0.1 −7.1 −4.1 −1.6
Financing
0.6 13.2 1.5 2.8 5.4 10.1 11.7 8.5 6.2

† The diluted share count jumps at 2022 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.